AstraZeneca CEO Soriot Pursues Multiple Strands in RNA Drug Discovery Push
AstraZeneca Plc , whose setbacks in drug development have made the stock the cheapest among the largest pharmaceutical companies, is turning to RNA technology to boost its chances of discovering new therapies.
Join the discussion below, or Read more at Bloomberg.
#1 Mar 31, 2013
I was recently told that there is a generic durg for NEXIUM called Izra-40 (Esomeprazole Tablets IP 40) IS THIS TRUE AND WHERE CAN I BUY.
Add your comments below
|Mumps outbreak probably isn't related to vaccin...||Apr 18||MMR||1|
|Bristol Palin says abstinence best path for teens (May '09)||Apr 3||Coonway Tweety||2,658|
|After Trump rally, equity investors move into h...||Mar '17||Retribution||6|
|N/R: Lack of mental, epileptic drugs hit health...||Mar '17||Humanspirit||1|
|The EpiPen debacle may be the shot heard around...||Feb '17||Suezanne||2|
|Despite $19 million salary, Mylan CEO failed to... (Sep '16)||Feb '17||Suezanne||3|
|Myriad Genetics Announces an Assay that Identif...||Feb '17||Purplemouse2||8|
Find what you want!
Search Biotech Forum Now
Copyright © 2017 Topix LLC